Prospective Evaluation of Elderly Deformity Surgery

NCT ID: NCT02035280

Last Updated: 2023-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

233 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As the population continues to age, the prevalence of spinal deformity surgery for older patients is increasing. Questions regarding the suitability of these patients to undergo large spinal procedures and whether the outcomes merit the risks involved are not well known.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

225 subjects greater than or equal 60 years of age with moderate and severe adult spinal deformity requiring surgical correction will be enrolled in a prospective multicenter international study. Spinal deformity will be defined as any coronal or sagittal plane spinal deformity in patients who have not undergone any previous spinal surgery (with the exception of prior decompression of a maximum of 2 levels) necessitating at a minimum a 5-level spinal fusion procedure. Standard radiographs and cross sectional imaging will be performed preoperatively, postoperatively, at 24 months and 5 years after surgery. Preoperative disease specific and general health questionnaires will be completed by all patients (EQ-5D, ODI, SRS-22r, NRS for back and leg pain). Follow up visits with questionnaires will be performed at 10 weeks (± 6 weeks), 12 months (± 2 months), 24 months (± 2 months) and 5 years (±6 months) post-operatively. All treatment-related AEs will be documented.

Regression analyses will be used to evaluate the association between patient demographics, comorbidities, treatment history, spinal deformity characteristics, surgical characteristics, treatment-related AEs and pre-surgical status to self-reported and radiographic outcomes after surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adult Spinal Deformity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elderly suffering of spine deformity

Spinal deformity patients over the age of 60 years undergoing elective surgery and requiring fusion of at least 5 levels.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 60 years or older at the time of surgery
* Diagnosis of adult spinal deformity either in the coronal or sagittal plane requiring at the minimum a 5-level spinal fusion procedure
* Ability to understand the content of the patient information / Informed Consent Form
* Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
* Signed and dated Institutional Review Board (IRB)/Ethics Committee (EC)-approved written informed consent
* Reconsent of patients for the 5 year follow-up if required by the IRB/EC

Exclusion Criteria

* Any previous spinal procedure (except prior decompression of a maximum of 2 levels)
* Neurodegenerative disease or paralysis
* Unlikely to comply with follow-up
* Institutionalized individuals
* Any not medically managed severe systemic disease
* Recent history (≤ 3 months) of substance abuse (ie, recreational drugs, alcohol) or psychosocial disturbance that would preclude reliable assessment
* Prisoner
* Presence of active malignancy
* Has active, overt bacterial infection, systemic or local
* History of recent(≤ 3 months) fracture/malignancy in the spinal region
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AO Innovation Translation Center

OTHER

Sponsor Role collaborator

AO Foundation, AO Spine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen Lewis, MD

Role: PRINCIPAL_INVESTIGATOR

University of Toronto

Sigurd Berven, MD

Role: PRINCIPAL_INVESTIGATOR

University of California, San Francisco

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UCSF Medical Center

San Francisco, California, United States

Site Status

University of Minnesota

Minneapolis, Minnesota, United States

Site Status

Washington University Orthopedics

St Louis, Missouri, United States

Site Status

New York Presbyterian - Columbia University Medical Center

New York, New York, United States

Site Status

University of Virginia

Charlottesville, Virginia, United States

Site Status

Toronto Western Hospital

Toronto, Ontario, Canada

Site Status

Queen Mary Hospital

Hong Kong, , China

Site Status

Nanjing University Medical School

Nanjing, , China

Site Status

Rigshospitalet

Copenhagen, , Denmark

Site Status

Hamamatsu University School of Medicine

Hamamatsu, , Japan

Site Status

St. Maartens Kliniek

Nijmegen, , Netherlands

Site Status

Hospital Vall d'Hebron

Barcelona, , Spain

Site Status

Aciboden Maser Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada China Denmark Japan Netherlands Spain Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEEDS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.